Abstract
Muraymycins are a subclass of antimicrobially active uridine-derived natural products. Biological data on several muraymycin analogues have been reported, including some inhibitory in vitro activities toward their target protein, the bacterial membrane enzyme MraY. However, a structure–activity relationship (SAR) study on naturally occurring muraymycins based on such in vitro data has been missing so far. In this work, we report a detailed SAR investigation on representatives of the four muraymycin subgroups A–D using a fluorescence-based in vitro MraY assay. For some muraymycins, inhibition of MraY with IC 50 values in the low-picomolar range was observed. These inhibitory potencies were compared with antibacterial activities and were correlated to modelling data derived from a previously reported X-ray crystal structure of MraY in complex with a muraymycin inhibitor. Overall, these results will pave the way for the development of muraymycin analogues with optimized properties as antibacterial drug candidates.
| Original language | English |
|---|---|
| Pages (from-to) | 779-784 |
| Number of pages | 6 |
| Journal | ChemMedChem |
| Volume | 13 |
| Issue number | 8 |
| DOIs | |
| State | Published - Apr 23 2018 |
Bibliographical note
Publisher Copyright:© 2018 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Funding
We thank the Deutsche Forschungsgemeinschaft (DFG, grant DU 1095/5-1, C.D.), the University of Kentucky College of Pharmacy, the University of Kentucky Markey Cancer Center, the National Center for Advancing Translational Sciences (UL1TR001998, X.W., J.S.T.) and the National Institutes of Health (NIH, grant AI087849, Z.C., S.G.V.L.) for financial support. P.D.F. is grateful for a doctoral fellowship of the Fonds der Chemischen Industrie (FCI). We also thank Professor Seok-Yong Lee (Duke University Medical Center) for providing us with the plasmid for the overexpression of MraY from A. aeolicus.
| Funders | Funder number |
|---|---|
| University of Kentucky | |
| National Institutes of Health (NIH) | |
| National Institute of Allergy and Infectious Diseases | R01AI087849 |
| National Institute of Allergy and Infectious Diseases | |
| National Center for Advancing Translational Sciences (NCATS) | UL1TR001998 |
| National Center for Advancing Translational Sciences (NCATS) | |
| Verband der Chemischen Industrie | |
| University of Kentucky Markey Cancer Center | |
| Deutsche Forschungsgemeinschaft | DU 1095/5-1 |
| Deutsche Forschungsgemeinschaft |
Keywords
- activity assays
- antibiotics
- natural products
- nucleosides
- structure–activity relationships
ASJC Scopus subject areas
- Drug Discovery
- General Pharmacology, Toxicology and Pharmaceutics
- Molecular Medicine
- Biochemistry
- Pharmacology
- Organic Chemistry